Combining multiple compounds that influence similar pathways may increase complexity and variability in outcomes
Some folks do best when they feel part of a community, whether thats an inapp group, live workshops, or a private group of friends and family
The manufacturer, Eli Lilly Co., has submitted orforglipron to the FDA for approval for use in weight management, with a decision expected in the second quarter of 2026
Final approval: FDA issues a formal decision
Additional information on the effects of subcutaneous semaglutide on cardiovascular events is being studied in approximately 17,500 overweight and obese subjects in the SELECT trial, with an estimated completion date of September 2023
This helps your system efficiently process glucose, preventing the spikes and crashes that can drive cravings